Relationship between high mobility group protein B1 level and helper T cell 17/regulatory T cell balance in patients with primary Sj?觟gren′s syndrome
LI Xue1 CHENG Ting1 REN Xiaoying1 WANG Juan1 HOU Ziqi1 LIANG Shufen2
1.The Second Clinical Medical College, Shanxi Medical University, Shanxi Province, Taiyuan 030001, China;
2.Department of Clinical Laboratory, the Second Hospital of Shanxi Medical University, Shanxi Province, Taiyuan 030000, China
Abstract：Objective To investigate the relationship between the level of high mobility group box 1 (HMGB1) and the balance of helper T cell 17 (Th17) /regulatory T cells (Treg) in peripheral blood of patients with primary Sjögren′s syndrome (pSS). Methods Forty patients with pSS in Rheumatology Department of the Second Hospital of Shanxi Medical University from May 2018 to May 2019 were selected as pSS group, and 20 healthy subjects were control group. Elbow venous blood was collected. The number of Th17 and Treg cells was detected by flow cytometry, and Th17/Treg ratio was calculated. Cytometric bead array was used to detect serum interleukin (IL)-17, IL-6 and IL-10 levels. Enzyme-linked immunosorbent was used to detect the levels of HMGB1 and transforming growth factor-β (TGF-β). Each of the above indicators was compared between two groups, and the correlation between HMGB1 and the expression of various cells and cytokines was analyzed. Results The levels of HMGB1, Th17 and Th17/Treg in pSS group were higher than those in control group, while Treg was lower than that in control group, and the difference was statistically significant (P < 0.05). The levels of IL-17, IL-6 and TGF-β in pSS group were higher than those in control group, while IL-10 was lower than that in control group, the differences were statistically significant (P < 0.05). Correlation analysis showed that HMGB1 was positively correlated with Th17, Th17/Treg, IL-17 and IL-6 levels (r = 0.738, 0.502, 0.762, 0.578， all P < 0.05). There was a negative correlation between the levels of HMGB1 and Treg, IL-10 (r = -0.657, -0.686, all P < 0.05), no significant correlation with TGF-β (P ＞ 0.05). Conclusion HMGB1 in peripheral blood of patients with pSS is abnormally high, and there is obvious T cell immune abnormality compared with healthy people, suggesting that HMGB1 may participate in the development of pSS by regulating Th17/Treg balance.
李雪1 程婷1 任效瑛1 王娟1 侯子琪1 梁树芬2. 原发性干燥综合征患者高迁移率族蛋白B1与辅助性T细胞17/调节性T细胞平衡的关系[J]. 中国医药导报, 2020, 17(4): 167-170.
LI Xue1 CHENG Ting1 REN Xiaoying1 WANG Juan1 HOU Ziqi1 LIANG Shufen2. Relationship between high mobility group protein B1 level and helper T cell 17/regulatory T cell balance in patients with primary Sj?觟gren′s syndrome. 中国医药导报, 2020, 17(4): 167-170.
[1] Alunno A，Carubbi F，Bistoni O，et al. T regulatory and T helper 17 cells in primary Sjögren′s syndrome： facts and perspectives [J]. Mediators Inflamm，2015，2015：243723.
[2] Zhu B，Zhu Q，Li NF，et al. Association of serum/plasma high mobility group box 1 with autoimmune diseases： a systematic review and meta-analysis [J]. Medicine，2018，97（29）：e11531.
[3] Dupire G，Nicaise C，Gangji V，et al. Increased serum levels of high-mobility group box 1 （HMGB1） in primary Sjögren′s syndrome [J]. Scand J Rheumatol，2012，41（2）：120-123.
[4] Ivanchenko M，Aqrawi LA，Björk A，et al. FoxP3+ CXCR5+ CD4+ T cell frequencies are increased in peripheral blood of patients with primary Sjögren′s syndrome [J]. Clin Exp Immunol，2019，195（3）：305-309.
[5] Vitali C，Bombardieri S，Jonsson R，et al. Classification criteria for Sjögren′s syndrome： a revised version of the European criteria proposed by the American-European Consensus Group [J]. Ann Rheum Dis，2002，61（6）：554-558.
[6] Kleinewietfeld M，Hafler DA. The plasticity of human Treg and Th17 cells and its role in autoimmunity [J]. Semin Immunol，2013，25（4）：305-312.
[7] Luo J，Ming BX，Zhang C，et al. IL-2 inhibition of Th17 generation rather than induction of Treg cells is impaired in primary Sj?ögren′s syndrome patients [J]. Front Immunol，2018，9：1755.
[8] van Hamburg JP，Tas SW. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis [J]. J Autoimmun，2018，87：69-81.
[9] Zafari P，Yari K，Mostafaei S，et al. Analysis of helios gene expression and Foxp3 TSDR methylation in the newly diagnosed rheumatoid arthritis patients [J]. Immunol Invest，2018，47（6）：632-642.
[10] Kosmaczewska A，Ciszak L，Szteblich A，et al. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus [J]. Postepy Hig Med Dosw （Online），2014，68：893-898.
[11] Hwang CS，Pitcher JD，Pangelinan SB，et al. Age-related T-cell cytokine profile parallels corneal disease severity in Sjögren′s syndrome-like keratoconjunctivitis sicca in CD25KO mice [J]. Rheumatology （Oxford），2010，49（2）：246-258.
[12] 厉小梅，李向培，钱龙，等.CD4+CD25+调节性T细胞在干燥综合征患者外周血和唇腺组织的表达[J].中华医学杂志，2007，87（15）：1034-1037.
[13] Miao M，Hao ZY，Guo YY，et al. Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren′s syndrome [J]. Ann Rheum Dis，2018，77（12）：1838-1840.
[14] Lee SA，Kwak MS，Kim S，et al. The role of high mobility group box 1 in innate immunity [J]. Yonsei Med J，2014， 55（5）：1165-1176.
[15] Herjan T，Hong L，Bubenik J，et al. IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling [J]. Nat Immunol，2018，19（4）：354-365.
[16] Zhang LH，Mo HY，Zhu MY，et al. Effect of cyclophosphamide on cytokines in patients with primary Sjögren′s syndrome-associated interstitial lung disease in South China [J]. Rheumatol Int，2013，33（6）：1403-1407.
[17] 杨敏，洪梦琴，许佳，等.原发性干燥综合征患者血清TNF-α、TGF-β1水平变化及意义[J].山东医药，2017， 57（32）：90-92.
[18] 闫慧明，丁利芳，刘媛，等.转化生长因子-β1与结缔组织生长因子在类风湿关节炎合并肺间质病变患者血清中的表达水平及临床意义[J].中国全科医学，2012， 15（28）：3268-3270.
[19] Ping X，Lu YP，Cao MH，et al. Mature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encepha-lomyelitis [J]. Cent Eur J Immunol，2016，41（2）：143-152.
[20] Jadidi-Niaragh F，Mirshafiey A. The deviated balance between regulatory T cell and Th17 in autoimmunity [J]. Immunopharmacol Immunotoxicol，2012，34（5）：727-739.
2020, Vol. 17 
京公网安备 11010502046598号